Submit Manuscript  

Article Details


Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis

[ Vol. 18 , Issue. 5 ]

Author(s):

Lian Li*, Jie Liu and Hua She*   Pages 366 - 371 ( 6 )

Abstract:


Background & Objective: Amyotrophic lateral sclerosis is a progressive neurodegenerative disease that specifically affects motor neurons in the brain and in the spinal cord. Patients with amyotrophic lateral sclerosis usually die from respiratory failure within 3 to 5 years from when the symptoms first appear. Currently, there is no cure for amyotrophic lateral sclerosis. Accumulating evidence suggests that dismantling of neuromuscular junction is an early event in the pathogenesis of amyotrophic lateral sclerosis.

Conclusion: It is starting to realized that macrophage malfunction contributes to the disruption of neuromuscular junction. Modulation of macrophage activation states may stabilize neuromuscular junction and provide protection against motor neuron degeneration in amyotrophic lateral sclerosis.

Keywords:

Amyotrophic lateral sclerosis, macrophage, inflammation, neuromuscular junction, peripheral nerve system, activation states.

Affiliation:

Translational Center for Stem Cell Research, Tongji Hospital, Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Translational Center for Stem Cell Research, Tongji Hospital, Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Translational Center for Stem Cell Research, Tongji Hospital, Stem Cell Research Center, Tongji University School of Medicine, Shanghai



Read Full-Text article